Dr. Mahmood Nazari was appointed CEO of PharmAI Discovery GmbH on July 1. With a PhD from TU Dresden and more than ten years of experience in the pharmaceutical industry, he brings a strong background at the intersection of artificial intelligence, nuclear medicine, and drug development. His expertise and leadership will guide PharmAI Discovery into its next phase of growth and further advance our AI-driven approach to drug discovery.
